The Merck LMP7 inhibitor, M3258, is an orally available, selective, and reversible inhibitor of the immunoproteasome proteolytic subunit, LMP7. In contrast to the constitutive proteasome, the immunoproteasome is predominantly expressed…
Home > M3258
this content is exclusive to
Premium members
Unlock this content with a Premium membership to read it now.